Skip to main content
T

TISSUE REPAIR LTD — Investor Relations & Filings

Ticker · TRP ISIN · AU0000180887 ASX Professional, scientific and technical activities
Filings indexed 27 across all filing types
Latest filing 2025-10-28 Regulatory Filings
Country AU Australia
Listing ASX TRP

About TISSUE REPAIR LTD

https://tissuerepair.com.au/

Tissue Repair Ltd is a clinical-stage biopharmaceutical company focused on the development of advanced wound healing and skin repair agents. The company’s core technology centers on Glucoprime, a proprietary yeast-derived beta-glucan designed to stimulate the innate immune system and accelerate the body's natural healing processes. Its lead candidate, TR-987, is being developed for the treatment of chronic wounds, such as venous leg ulcers, and for use in post-procedural recovery following aesthetic treatments. By targeting the inflammatory phase of wound healing, the technology aims to improve clinical outcomes and reduce recovery times. The company focuses on addressing unmet needs in both the medical wound care and cosmetic dermatology markets through its specialized biological platform.

Recent filings

Filing Released Lang Actions
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 468.1KB
Regulatory Filings
2025-10-28 English
2025 Notice of Annual General Meeting and Proxy Form 58 pages 1.7MB
Regulatory Filings
2025-10-21 English
2025 Annual General Meeting Date 1 page 130.1KB
Regulatory Filings
2025-09-25 English
Appendix 4E and Annual Report 30 June 2025 51 pages 1.7MB
Regulatory Filings
2025-08-28 English
Appendix 4G and Corporate Governance Statement 24 pages 697.1KB
Regulatory Filings
2025-08-28 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 445.6KB
Regulatory Filings
2025-07-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.